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Induction of oxidative metabolism 
by the p38α/MK2 pathway
Natalia Trempolec1, Juan Pablo Muñoz  1,2,3, Konstantin Slobodnyuk1, Silvia Marin2,4,  
Marta Cascante2,4, Antonio Zorzano1,2,3 & Angel R. Nebreda1,5
Adequate responses to environmental stresses are essential for cell survival. The regulation of cellular 
energetics that involves mitochondrial energy production and oxidative stress is central in the process 
of stress adaptation and response. The p38α signalling pathway plays a key role in the response to 
stress stimuli by orchestrating multiple cellular processes. However, prolonged activation of the 
p38α pathway results in impaired cell proliferation and can lead to cell death. Here we use a system 
to specifically activate p38α signalling and show that sustained activation of this pathway suffices to 
induce important metabolic changes, including high dependence on glucose for cell survival, increased 
consumption of glutamine, enhanced respiration rate and elevated production of mitochondrial 
reactive oxygen species (ROS). Moreover, we provide evidence that increased production of 
mitochondrial superoxide as a consequence of elevated mitochondria activity, contributes to the p38α 
reduced cell survival triggered by sustained p38α activation. We also show that the p38α-activated 
kinase MAPKAPK2 (MK2) plays an important role orchestrating the observed metabolic changes. Our 
results illustrate a new function of p38α signalling in the regulation of cellular metabolism, which may 
lead to cell death upon persistent activation of the pathway.
Proper responses to environmental stresses are critical for cell survival. Therefore, cells have developed sophisti-
cated systems to receive and interpret stress signals. One of the pathways that plays an important role in the regu-
lation of the stress response is orchestrated by the p38α serine-threonine protein kinase. p38α is a member of the 
mitogen-activated protein kinase (MAPK) family that is expressed in most tissues1, 2, and is normally activated 
by the dual-specificity MAPK kinases (MKKs) MKK3 or MKK6. The ability of p38α to phosphorylate a wide 
range of downstream substrates, including several transcriptional factors and other protein kinases, makes it an 
important regulator of cell proliferation, survival and differentiation, affecting multiple physiological processes3, 4. 
MAPKAPK-2 (also known as MK2) is one of the p38α substrates, which has been implicated in signalling events 
affecting the regulation of stress and inflammatory responses. MK2 can phosphorylate several proteins involved 
in transcriptional regulation, mRNA stability and other processes broadening the targets of the p38α pathway5.
The regulation of cell metabolism and mitochondrial energy production is central for cells to be able to adapt 
to stressful situations. A clear case of metabolic reprogramming is observed in cancer cells, which display impor-
tant metabolic changes in order to support their elevated anabolic, energetic and redox demands6, 7. Based on 
these characteristics, new therapeutic approaches have been proposed by targeting mitochondrial function or 
using anti-glycolytic agents to overcome the resistance of cancer cells to conventional chemotherapy. Several 
signalling pathways and transcriptional regulators have been implicated in the modulation of cancer cell metab-
olism, with c-Myc, and PPARγ cofactor-1α (PGC1α) playing an important role in key biosynthetic processes and 
mitochondria generation8–11.
There is some evidence implicating p38α signalling in the regulation of metabolism in specific cell types, for 
example controlling glucose uptake in adipocytes and cardiac myocytes12–14, or gluconeogenesis in hepatocytes15, 16, 
but the role of p38α in cancer cell metabolism has not been investigated. Here we have investigated the effects 
of p38α activation on the metabolism of U2OS cancer cells. We show that sustained p38α activation increases 
nutrient consumption, with particularly high demands on glucose, and boosts mitochondrial efficiency, increas-
ing mitochondrial mass and maximizing oxidative phosphorylation. This in turn elevates oxygen consumption 
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resulting in the production of mitochondrial reactive oxygen species (ROS) that sensitize to cell death. Our results 
also indicate that MK2 plays a key role mediating the metabolic changes induced by p38α activation.
Results
Sustained activation of the p38α pathway triggers high dependence on glucose. To better 
understand the effects triggered by activation of the p38α signalling pathway, we developed an inducible system 
to express MKK6DD, a constitutively active form of the specific p38 MAPK activator MKK6, under the control of 
the TET-ON promoter in U2OS cells. Induction of MKK6DD (hereafter referred to as MKK6) upon addition of 
tetracycline led to the detection of two bands that were recognized with an antibody specific for the phosphoryl-
ated (and active) form of p38 MAPKs (Fig. 1a). Using specific shRNAs, we identified the lower band as p38α and 
the upper band as p38γ (Supplementary Fig. S1a and b). MKK6 expression rapidly increased the phosphorylation 
of p38α, which correlated with enhanced phosphorylation of the p38α substrate MK2 and its downstream target 
Hsp27, whereas p38γ showed somewhat slower kinetics of activation (Fig. 1a). We found that MKK6 expression 
reduced U2OS cell proliferation, as previously reported17, and this effect was rescued by either chemical inhibi-
tion or downregulation of p38α but it was not affected by p38γ downregulation (Supplementary Fig. S1c).
The p38α pathway can be activated by multiple stresses, including nutrient deprivation18. Given the impor-
tance of glucose metabolism in cancer cells, we decided to investigate how direct activation of p38α signalling 
affected glucose metabolism in U2OS cells. We found that MKK6 expression led to high dependence on glucose, 
as shown by a dramatic decrease in cell viability under glucose-deprived conditions (Fig. 1b and c). The high 
dependence on glucose correlated with increased glucose uptake, detected 24 h after MKK6 expression, which 
was reversed upon inhibition of p38α using the chemical compound PH-797804 (Fig. 1d). Consistent with the 
above observations, MKK6 expression for 8 h induced the upregulation of mRNAs encoding the glucose trans-
porter GLUT1, hexokinase 2 (HK2) and 6-phosphofructo-2-kinase (PFKFB3) (Fig. 1e). Additionally, 24 h after 
MKK6 expression, we detected increased expression of glutaminase-1 (GLS1), which generates glutamate from 
glutamine during the first step of glutamine metabolism (Fig. 1e). Indeed, p38α activation led also to enhanced 
glutamine consumption (Fig. 1f).
The activation of p38α did not seem to affect the tricarboxylic acid (TCA) reaction, as supplementation of 
glucose depleted media with dimethyl-2-ketoglutarate (αKG), a cell membrane-permeable precursor of key TCA 
intermediates, led to a significant increase in the survival of MKK6 expressing cells under glucose deprived con-
ditions (Fig. 1g). Interestingly, cell death induced by glucose deprivation was also rescued by supplementation of 
the media with pyruvate (Fig. 1g), suggesting that p38α activation leads to changes in the cell metabolism in such 
a way that glucose becomes essential for mitochondrial metabolism.
p38α activation increases glucose oxidation and fatty acid synthesis. Next, we analysed the 
impact of p38α activation on the utilization of substrates. We found that MKK6 expressing cells showed increased 
lipid droplet content, detected by Nile Red, which was impaired upon inhibition of p38α with PH-797804 (Fig. 2a 
and Supplementary Fig. S2). Lipid droplets can function as intracellular sites of neutral lipid storage, and are 
critical not only for lipid metabolism but also for energy homeostasis with their dysfunction being linked to 
multiple pathologies. Most of the carbon required for fatty acid synthesis comes from glucose delivered pyru-
vate, which after conversion to acetyl-CoA in mitochondria is excreted into the cytosol in the form of citrate for 
further lipid synthesis10. Using 14C-glucose we confirmed increased glucose incorporation into de novo synthe-
sized lipids (Fig. 2b). The mitochondrial pyruvate dehydrogenase (PDH) complex plays a gatekeeper’s role in the 
regulation of carbon-flux by converting pyruvate into acetyl-CoA. Expression of MKK6 reduced the inhibitory 
phosphorylation of the E1α subunit of PDH (PDHA1), which was reversed by PH-797804, suggesting that p38α 
signalling positively regulates the activity of PDH leading to increased pyruvate oxidation (Fig. 2c). Consistent 
with this possibility, we detected that MKK6 expression increased the oxygen consumption rate (OCR) in basal 
(routine) conditions, which was mediated by p38α activation, based on its reversion by PH-797804 (Fig. 2d and 
Supplementary Fig. S3). The OCR increase was at least partly coupled to ATP production, since it was reduced 
in the presence of Oligomycin (Fig. 2d). Moreover, the enhanced metabolic rate correlated with an increased 
extracellular acidification rate (ECAR) (Fig. 2e), which predominately reflects the secretion of lactic acid after 
its conversion from pyruvate19. However, additional metabolic processes, such as CO2 production by the TCA 
cycle, can also lead to ECAR changes20. We also found that MKK6 expressing cells secreted more lactate (Fig. 2f), 
suggesting that sustained activation of p38α leads to increased glycolysis in addition to enhanced glucose oxida-
tion. Recently, it has been shown that tetracyclines, even at low concentration, can induce mitochondrial prote-
otoxic stress, leading to changes in mitochondrial dynamics and function21. To rule out the possibility that the 
effects mentioned above could be induced by tetracycline treatment independently of MKK6 expression, we used 
parental U2OS cells without the inducible system to express MKK6. We found that treatment of these cells with 
tetracycline neither activated the p38α pathway (Supplementary Fig. S4a) nor increased OCR, which if anything 
slightly decreased in both basal and maximum respiration rate (Supplementary Fig. S4b). These results support 
the positive effect of p38α signalling on mitochondria functionality.
p38α activation induces mitochondrial biogenesis. Increased mitochondrial respiration can be due 
to changes in either the mitochondrial mass or the mitochondrial functionality. Staining with Mitotracker Deep 
Red showed that MKK6 induction increased the mitochondrial compartment and this effect was reversed by 
p38α inhibition (Fig. 3a), but was not observed in tetracycline-treated U2OS cells that do not express MKK6 
(Supplementary Fig. S4c). Consistent with the idea that p38α activation induced mitochondrial biogenesis, we 
observed the p38α-induced upregulation of Voltage-dependent anion-selective channel protein 1 (VDAC1), a 
porin located in the outer membrane of mitochondria (Fig. 3b). Immunoblot analysis of isolated mitochondria 
further supported the enhanced mitochondria biogenesis in MKK6-expressing cells, based on the accumulation 
www.nature.com/scientificreports/
3SCIENtIfIC REPORTS | 7: 11367  | DOI:10.1038/s41598-017-11309-7
Figure 1. MKK6 expression makes cells highly dependent on glucose for survival. U2OS cells expressing a 
Tet-regulated construct were either mock treated (control) or treated with tetracycline for the indicated times 
to induce the expression of constitutively active MKK6. (a) Total cell lysates were analysed by immunoblotting 
using the indicated antibodies. Phosphorylated p38α and p38γ are indicated by arrowheads. The uncropped 
immunoblots are presented in Supplementary Fig. S8. (b) Control and MKK6 expressing cells were incubated in 
complete media or glucose free media for 24 h and cell survival was assayed using Annexin V/PI staining. Live 
cells were determined as the cell population Annexin V− and PI−. (c) Morphology of cells cultured in complete 
or glucose free media for 24 h. Bars = 50 μm. (d) Glucose consumption by control, MKK6 expressing cells and 
MKK6 expressing cells treated with the p38α inhibitor PH797804 (PH) were measured at the indicated times 
and presented as μmol × 106 cells−1 × h−1. (e) Control and MKK6 expressing cells were grown in the presence 
or absence of the p38α inhibitor PH797804 (PH) for the indicated times and the expression levels of mRNAs 
encoding glycolytic genes and GLS1 was analysed. Results are presented as fold change towards control. (f) 
Glutamine consumption was determined as in (d). (g) Control and MKK6 expressing cells were grown for 24 h 
in complete (+Glc) and glucose depleted media (−Glc) supplemented with 2 mM pyruvate or 1 mM dimethyl-
2-ketoglutarate (αKG), as indicated, and cell survival was assayed using Annexin V/PI staining.
www.nature.com/scientificreports/
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of the mitochondrial transcription factor A (TFAM), which controls transcription of mitochondrial DNA 
encoded genes as well as DNA replication during biogenesis (Fig. 3c). This increased presence of TFAM in mito-
chondria agrees with the increased mitochondrial DNA copy number normalized by genomic DNA copy number 
induced by MKK6 expression (Fig. 3d). These changes correlated with increased mitochondrial functionality, 
as determined both by elevated ATP production (Fig. 3e) and by enhanced mitochondrial membrane potential 
(Fig. 3f). Two factors involved in canonical mitochondria biogenesis are c-Myc and PGC1α22–24. We found that 
p38α activation increased the expression of both (Supplementary Fig. S5a and b), but knocking down c-Myc or 
PGC1α did not affect the increased mitochondrial mass observed in MKK6 expressing cells (Supplementary 
Fig. S5c–f).
Correct mitochondrial dynamics is essential for cell survival and is subjected to rapid changes in response to 
external insults and metabolic status25. Curiously, we observed that MKK6 expression induced the fragmentation 
Figure 2. Metabolic changes triggered by MKK6 expression. U2OS cells expressing a Tet-regulated construct 
were either mock treated (control) or treated with tetracycline for the indicated times to induce the expression 
of constitutively active MKK6. (a) Lipid droplet content was quantified 24 h and 48 h after MKK6 induction 
in the presence or absence of the p38α inhibitor PH797804 (PH). (b) Incorporation of 14C-glucose into newly 
synthesized proteins and lipids was analysed 24 h after MKK6 induction, and is represented as fold change 
towards control. (c) Total lysates from control and MKK6 expressing cells in the presence or absence of PH 
were analysed by immunoblotting using the indicated antibodies. The uncropped immunoblots are presented 
in Supplementary Fig. S8. (d) The oxygen consumption rate was analysed 12 h after the induction of MKK6 
expression in the presence or absence of PH. Results are presented as pmoles of O2 consumed per 105 cells. (e) 
The extracellular acidification rate was measured 12 h after the induction of MKK6 in the presence or absence of 
PH. Results are presented as pmoles of secreted H+ per 105 cells. (f) Lactate production was measured in control 
and MKK6 expressing cells at 32 h, and is presented as μmol × 106 cells−1 × h−1.
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Figure 3. MKK6 expression affects mitochondria function. U2OS cells expressing a Tet-regulated construct 
were either mock treated (control) or treated with tetracycline for the indicated times to induce the expression 
of constitutively active MKK6. (a) Mitochondrial mass in control and MKK6 expressing cells was measured 
using MitoTracker Deep Red at the indicated times, and is represented as fold change versus the control. (b) 
Total lysates from control and MKK6 expressing cells were analysed by immunoblotting. (c) Mitochondria 
were extracted from control and MKK6 expressing cells in the presence or absence of the p38α inhibitor 
PH797804 (PH) for 24 h. Expression of the indicated mitochondrial proteins was analysed by immunoblotting. 
The uncropped immunoblots are presented in Supplementary Fig. S8. (d) The ratio of mitochondrial DNA 
(mtDNA) versus genomic DNA (gDNA) was analysed in control and MKK6 expressing cells in the presence 
or absence of PH for 24 h. (e) ATP levels were analysed at the indicated times after MKK6 induction in the 
presence or absence PH and were normalized towards the cell number. Values were standardised towards 
control cells. (f) Mitochondrial membrane potential in control and MKK6-expressing cells in the presence or 
absence of PH was measured at 12 and 24 h. (g) Quantification of control and MKK6 expressing cells at 24 h that 
contain tubular (T), fragmented (F) and donut (D) mitochondria visualized with Tom 20 staining. Bar = 10 μM.
www.nature.com/scientificreports/
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of mitochondria resulting in reduced number of tubular structures and appearance of more rounded structures 
(Fig. 3g).
Mitochondrial superoxide production contributes to p38α-induced cell death. Mitochondrial 
fission is linked to apoptosis26. We found that expression of MKK6 resulted in reduced cell survival, which 
started to be detected at 24 h by Annexin V and PI staining, and was reversed by p38α inhibition (Fig. 4a and 
Figure 4. Increased mitochondrial ROS contributes to cell death induced by MKK6 expression. U2OS cells 
expressing a Tet-regulated construct were either mock treated (control) or treated with tetracycline for the 
indicated times to induce the expression of constitutively active MKK6. (a) Cell survival was assayed at the 
indicated times using Annexin V/PI staining. Live cells were determined as the cell population Annexin V− and 
PI−. (b) Intracellular ammonia accumulation was measured in control and MKK6 expressing cells at 32 h and is 
presented as nmol / 5 × 104 cells. (c) Total ROS levels were analysed at the indicated times after MKK6 induction 
using the DCFH-DA probe. Values are presented as fold change of mean fluorescence of DCF versus the control 
cells. (d) ROS levels in control and MKK6 expressing cells treated for 24 h with the p38α inhibitors PH797804 
(PH) or SB203580 (SB) were analysed using the DCFH-DA probe. Values are presented as fold change in the 
mean fluorescence of DCF. (e) Mitochondrial ROS levels in control and MKK6 expressing cells either mock-
treated or treated with SB were evaluated at 24 h using the MitoSox probe. Values are represented as fold change 
in the mean fluoresce of MitoSox normalized towards control cells.
www.nature.com/scientificreports/
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Supplementary Fig. S6a). Further analysis showed that treatment with the caspase inhibitors Z-VAD or Q-VD par-
tially but significantly prevented the decline in live cell population triggered by MKK6 expression (Supplementary 
Fig. S6b). These results suggested that MKK6 expression probably induced a combination of different types of 
cell death, mediated by both caspase-dependent and independent events. On the other hand, treatment with the 
necrosis inhibitor Nec-1 did not affect the cell death triggered by MKK6 expression (Supplementary Fig. S6c).
Our results indicated that the p38α-induced metabolic reprogramming was already detected at 12 h, as deter-
mined by increased cell respiration, mitochondrial biomass and increased glucose consumption, which therefore 
preceded cell death that started to be detected at 24 h after p38α activation. The accelerated cell metabolism 
induced by expression of MKK6 also led to the enhanced generation of metabolic side products such as lactate 
(see Fig. 2f above) and ammonium (Fig. 4b), as well increased generation in ROS (Fig. 4c). The ROS increase 
required activation of p38α, as it was reversed by chemical inhibition of p38α (Fig. 4d) or by downregulation of 
p38α but it was not affected by p38γ downregulation (Supplementary Fig. S1d). Using the mitochondrial-specific 
probe MitoSox, we also detected increased mitochondrial ROS after MKK6 expression, which was reversed 
by the inhibition of p38α (Fig. 4e). However, consistent with the idea that p38α-induced metabolic changes 
precede cell death, the caspase inhibitor Z-VAD did not affect the MKK6-induced mitochondrial ROS increase 
(Supplementary Fig. S6d). Importantly, neither mitochondrial ROS nor cell survival levels were affected in 
tetracycline-treated U2OS cells that do not express MKK6 (Supplementary Fig. S4d and e).
The intracellular antioxidant system is key to maintain the redox balance in the cell. A very important intracel-
lular antioxidant is GSH that detoxifies H2O2 via GSH peroxidases giving rise to oxidized GSH (GSSG), which is 
then reduced into GSH by GSH reductase using NADPH as the electron donor. We found that MKK6 expression 
did not affect the levels of total or reduced GSH (Fig. 5a), suggesting that ROS did not increase due to the declined 
efficiency of the intracellular antioxidant system. This result was confirmed by treatment of MKK6 expressing 
cells with canonical antioxidants, such as NAC (N-acetyl cysteine) and GSH, which failed to reverse the ROS 
increase (Fig. 5b). On the other hand, the mitochondria-targeted antioxidant MitoQ27 decreased ROS induc-
tion by MKK6 (Fig. 5c). Interestingly, MitoQ substantially rescued the cell death triggered by MKK6 expression, 
suggesting that mitochondrial ROS contributes to the process (Fig. 5d). In order to investigate if superoxide 
production was associated with mitochondrial activity, we analysed whether MitoQ affected the OCR of MKK6 
expressing cells. Addition of MitoQ to the cellular media has been shown to reduce oxygen consumption, which 
may be mediated by the inhibition of complex I of mitochondria independently of its antioxidant function28, 29. 
Accordingly, we found that incubation with MitoQ for 24 h decreased OCR in both control and MKK6 expressing 
cells (Fig. 5e), suggesting that superoxide generated due to increased activation of the respiratory chain leads to 
cell death.
Metabolic changes induced by p38α activation are mediated by MK2. The protein kinase MK2 is 
a well-known substrate of p38α, whose activation was induced upon MKK6 expression (Fig. 1a). Little is known 
on the implication of MK2 in cell metabolism, although MK2 has been reported to mediate the stress-induced 
increase in glycolysis by upregulation of PFKFB330. We decided to study the implication of MK2 in the metabolic 
changes induced by p38α activation. First, we found that a chemical inhibitor of MK2 reversed the increase 
in glucose and glutamine uptake induced by MKK6 expression (Fig. 6a and b), which correlated with reduced 
expression of GLUT1, PFKFB3 and GLS1 (Fig. 6c). Importantly, we confirmed that the chemical inhibitor 
impaired MK2 activity, as shown by the lack of Hsp27 phosphorylation, but did not affect p38 MAPK activity, 
as shown by the phosphorylation of MK2 itself (Fig. 6d). Interestingly, inhibition of MK2 reduced the cell death 
triggered by glucose deprivation in MKK6-expressing cells (Fig. 6e), supporting that metabolic changes mediated 
by MK2 sensitize the MKK6-expressing cells to the absence of glucose.
We also found that inhibition of MK2 using two different chemical compounds significantly improved the 
survival of cells in response to MKK6 expression (Fig. 7a). Thus, we investigated the implication of MK2 in the 
increased oxidative metabolism that correlated with reduced viability of MKK6 expressing cells. Experiments 
using MK2 inhibitors revealed that the MKK6-induced mitochondrial ROS increase (Fig. 7b), as well as the 
enhanced mitochondrial mass (Fig. 7c) and oxygen consumption rate (Fig. 7d) were all mediated by MK2. 
Additionally, we found that MK2 activation was involved in the mitochondrial proton motive force, as MK2 inhi-
bition reversed the increased mitochondria membrane potential (Fig. 7e) and elevated ATP production induced 
by MKK6 expression (Fig. 7f). Interestingly, we found that in contrast to MK2, chemical inhibition of MNK 
and MSK, two other protein kinases that can be directly activated by p38α2, did not affect cell death induced by 
MKK6 expression (Supplementary Fig. S7a and b). In agreement with the idea that p38α-induced mitochondrial 
dysfunction and enhanced ROS production were related to the observed cell death, we found that inhibition of 
MNK or MSK signalling reduced neither the mitochondrial mass increase nor the production of mitochondrial 
ROS induced by MKK6 expression (Supplementary Fig. S7c and d). Taken together, our results provide evidence 
for a novel role of the p38α pathway in the regulation of the mitochondrial mass and mitochondrial dependent 
ROS production, which is mainly mediated by MK2 activation.
Discussion
Cells exposed to environmental stresses require signalling flexibility to generate the responses necessary to 
recover from insults. However, if the stress persists or inadequate stimulation or repression of particular signal-
ling pathways occurs, cell death programs are often activated. The p38α pathway mediates intracellular signalling 
triggered by a variety of stimuli, which impinge on functions such as cell proliferation, differentiation and sur-
vival2. The different outcomes of p38α signalling can be due to the extent of pathway activity, with sustained p38α 
activation more likely to result in cell death, whereas transient or low levels of p38α activity are usually associated 
with homeostatic functions and cell survival2, 31, 32.
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We have used a cellular system based on inducible MKK6 expression to specifically activate the p38 MAPK 
pathway and recapitulate potential pathological states associated with p38α hyper-activation. Our studies show 
that sustained activation of p38α in U2OS cancer cells leads to a striking dependence on glucose for cell sur-
vival, which correlates with increased glucose consumption and glycolysis rate. Altered glucose metabolism is an 
important feature of cancer cells, which metabolize glucose mainly through glycolysis, with mitochondria being 
reprogrammed for macromolecular synthesis10, 11. Enhanced glucose consumption triggered by p38α activation, 
can be due to increased demand for glycolytic intermediates, used for fatty acids and nucleotide synthesis as well 
as for protein acetylation. Increased flux of pyruvate into the essential glycolytic intermediate acetyl-CoA was 
supported by the increased PDH activity and the elevation in glucose-dependent lipid content observed upon 
p38α activation. Our results showing that addition of pyruvate allows cells with hyperactive p38α to survive in 
glucose-free medium, indicate that these cells are highly dependent on pyruvate for their anaplerotic reactions.
Figure 5. MKK6 expression accelerates cell metabolism. U2OS cells expressing a Tet-regulated construct 
were either mock treated (control) or treated with tetracycline for the indicated times to induce the expression 
of constitutively active MKK6. (a) GSH content (total and reduced) were analysed in control and MKK6 
expressing cells at 24 h and presented as μmol/103 cells. (b) ROS levels in control and MKK6 expressing cells 
treated with NAC (5 mM) and GSH (5 mM) were analysed at 24 h after MKK6 induction using the DCFH-DA 
probe. (c) ROS levels in control and MKK6 expressing cells treated with MitoQ (500 nM) were analysed at 
24 h using the DCFH-DA probe. (d) Control and MKK6 expressing cells were treated with MitoQ (500 nM) 
for 2 days and cell survival was analysed by Annexin V/PI staining. Data were taken from 3 independent 
experiments. (e) The oxygen consumption rate was analysed 24 h after the induction of MKK6 expression in 
routine conditions and after addition of MitoQ (500 nM), as indicated. Results are presented as pmoles of O2 
consumed per 105 cells.
www.nature.com/scientificreports/
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The metabolic boost observed upon sustained p38α activation, led us to explore the effect on mitochondrial 
metabolism. Activation of p38α suffices to induce oxidative phosphorylation, as determined by the elevated OCR, 
which was accompanied by increased mitochondrial mass. Changes in the mitochondria content can be due 
either to mitochondrial biogenesis or to defects in mitophagy, and we provide evidence that p38α activation 
increases mitochondrial biogenesis. Additionally, we show that cells with sustained p38α activity possess func-
tional mitochondria, exhibiting increased mitochondrial membrane potential, ATP production and OCR. These 
Figure 6. MK2 mediates the MKK6-induced metabolic changes. U2OS cells expressing a Tet-regulated 
construct were either mock treated (control) or treated with tetracycline for the indicated times to induce the 
expression of constitutively active MKK6. (a and b) Glucose consumption (a) and glutamine consumption 
(b) by control, MKK6 expressing cells and MKK6 expressing cells treated with the MK2 inhibitor PF3644022 
(MK2i) were measured at the indicated times and presented as μmol × 106 cells−1 × h−1. These samples were 
processed in parallel and using the same control and MKK6 expressing cells as the samples presented in Fig. 1d 
and f. (c) The expression levels of mRNAs encoding proteins involved in glycolysis and glutaminolysis were 
determined by qRT-PCR after MKK6 induction in the presence or absence of the MK2 inhibitor III (MK2i-
III) for the indicated times. (d) Total cell lysates were prepared from control and MKK6 expressing cells in the 
presence or absence of the p38α inhibitor PH797804 (PH) or the MK2 inhibitor PF3644022 (MK2i), and were 
analysed by immunoblotting using the indicated antibodies. The uncropped immunoblots are presented in 
Supplementary Fig. S8. (e) Control and MKK6 expressing cells were grown in glucose-deprived conditions in 
the presence or absence of MK2i for 24 h, and cell survival was assayed using Annexin V/PI staining. Live cells 
were determined as the cell population Annexin V− and PI−.
www.nature.com/scientificreports/
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Figure 7. MK2 mediates changes in mitochondrial function induced by MKK6 expression. U2OS cells 
expressing a Tet-regulated construct were either mock treated (control) or treated with tetracycline for the 
indicated times to induce the expression of constitutively active MKK6. (a) Control and MKK6 expressing cells 
were grown in complete medium in the presence or absence of the MK2 inhibitors PF3644022 (MK2i) or MK2 
inhibitor III (MK2i-III) for 3 days, and cell survival was assayed using Annexin V/PI staining. Live cells were 
determined as the cell population Annexin V− and PI−. (b) Control and MKK6 expressing cells were incubated 
with MK2i or MK2i-III for 24 h, and mitochondrial ROS levels were analysed using the MitoSox probe. Values 
are represented as fold change in the mean fluorescence of MitoSox normalized towards control. (c) Control 
and MKK6 expressing cells were incubated with MK2i for 24 h and mitochondrial mass was analysed by 
Mitotracker Deep Red. Values are represented as fold change versus the control. (d) The oxygen consumption 
rate was analysed 24 h after the induction of MKK6 expression in the presence or absence of MK2i. Results 
are presented as pmoles of consumed O2 per 105 cells. (e) Mitochondrial membrane potential in control and 
MKK6 expressing cells in the presence or absence of PH or MK2i was measured at the indicated times. (f) ATP 
levels were analysed at the indicated times after MKK6 induction in the presence or absence of MK2i, and were 
normalized towards the cell number.
www.nature.com/scientificreports/
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changes are accompanied by increased expression of PGC1α, a key regulator of mitochondrial biogenesis, which 
can be positively regulated by p38α both at transcriptional and post-transcriptional levels33, 34. However, PGC1α 
downregulation does not affect the increase in mitochondrial biogenesis induced by p38α signalling, suggesting 
the implication of other p38α-regulated factors.
The regulation of metabolism and cell death are interconnected at multiple levels, with several proteins that 
control cell death being also implicated in metabolic regulation35. Increased nutrient uptake and glucose oxi-
dation are in principle beneficial for highly proliferative cells, but when raised above certain limits, can cause 
detrimental effects due to the accumulation of side metabolites such as mitochondrial ROS. The mitochondrial 
electron transport chain, which sets up the proton motive force, is one of the most important sources for ATP 
and intracellular ROS production36, 37. Our results indicate that increased OCR and mitochondrial ROS pro-
duction contribute to cell death induced by sustained p38α activation, based on the rescue observed using the 
mitochondrial specific antioxidant MitoQ38. Interestingly, this resembles the effect of dichloroacetic acid (DCA), 
a chemical inhibitor of PDH that enhances oxidative phosphorylation resulting in increased mitochondrial ROS 
and mitochondria-dependent apoptosis39. The reduced metabolic flexibility triggered by sustained activation of 
the p38α pathway might contribute to the high dependence on glucose for the survival of these cells.
MK2 is a well-established substrate of p38α involved in multiple cellular processes5. We found that MK2 
plays an important role mediating the p38α triggered metabolic changes that lead to increased glucose consump-
tion and reduced cell viability. Additionally, we show a new role of MK2 in increasing mitochondrial mass and 
activity. MK2 can phosphorylate the transcription factor CREB40, which has been implicated in the regulation 
of mitochondrial function41. Therefore, it is possible that the MKK6 induced changes in mitochondrial mass and 
functionality could be mediated by the MK2/CREB axis.
In summary, we provide evidence for a novel role of the p38α pathway increasing both ATP coupled and 
uncoupled respiration. The effects are triggered by specific activation of p38α signalling, which probably affects 
cell metabolism in a pleiotropic manner. The metabolic boost observed upon sustained p38α activation is prob-
ably beneficial for the cell in the early stages as it increases energy input and generates building blocks. However, 
sustained p38α activation beyond a certain threshold eventually leads to mitochondria dysfunction and reduced 
cell viability, emphasizing the importance of negative feed-back loops to restrain the extent of signalling pathway 
activation for proper cell homeostasis. Our results suggest that deregulated p38α signalling might contribute to 
human pathologies such as ageing and neurodegenerative disorders that are associated with impaired mitochon-
drial functions and ROS balance42, 43. Of note, increased OCR and ROS production induced by interfering with 
PDH activity has been shown to decrease tumour growth39, suggesting that sustained p38α activation could be 
beneficial to treat highly proliferative tumours.
Methods
Cell culture. U2OS cells (purchased from ATCC) were cultured in Dulbecco’s modified Eagle medium 
(DMEM, Sigma, D5796) supplemented with 10% fetal bovine serum (FBS, Thermo Scientific, E6541L), 2 mM 
L-Glutamine (LabClinics, M11–004) and 100 μg/ml penicillin-streptomycin (LabClinics, P11-010). For the inhi-
bition of p38α, we used 1 μM PH-797804 (Selleckchem, S2726) or 10 μM SB203580 (Axon MedChem); both com-
pounds can also inhibit p38β, although PH-797804 has been reported to preferentially inhibit p38α44. MK2 was 
inhibited using 10 μM MK-2 Inhibitor III (Calbiochem) or 10 μM PF 3644022 (Sigma, PZ0188), whereas MSK 
activity was inhibited using 5 μM SB 747651 (Axon MedChem), and MNK activity was inhibited using 10 μM 
CGP-57380 (Sigma). MitoQ (kind gift from M. Murphy, Cambridge, UK) was used at 0.5 μM. Cisplatin was used 
at 50 μM, and the caspase inhibitors Z-VAD(OMe)-FMK (SM Biochemicals LLC SMFMK001) and Q-VD-OPH 
(SM Biochemicals LLC SMPH001) at 50 μM. The inhibitors were dissolved in DMSO and the total concentration 
of DMSO in the culture medium did not exceed 1%.
Generation of cells expressing constitutively active MKK6. U2OS cells were transfected with the 
constructs pcDNA4 TO (Invitrogen) and pcDNA6-MKK6DD using NanoJuice (Merc Millipore). MKK6DD is a 
constitutively active form of the specific p38 MAPK activator MKK6 with the activation loop residues Ser207 and 
Thr221 mutated to Asp. After transfection, cells were trypsinized, plated at dilutions of 1:4, 1:3 and 1:2, and grown 
in media containing 4 μg/ml Blasticidin S HCl (Invitrogen, A11139-03) and 35 μg/ml of Zeozin (Invitrogen, 
R250-01). Media was changed every 3 days and when colonies were large enough, they were picked and replated 
in a 24-well plate. Selected clones were amplified and tested for p38 MAPK activation. To induce MKK6DD 
expression, cells were plated at 2.5 × 105 for a 6-well plate, 5 × 105 for a 60-mm plate or 1.2 × 106 for a 10-cm plate 
and when they reached 85% confluence, fresh media containing 1 μg/ml tetracycline (Sigma 87128-25 G) or the 
corresponding amount of ethanol (1:1000 dilution) was added. Tetracycline stocks were prepared in ethanol at 
1 mg/ml and stored at −20 °C.
Infection with shRNA-expressing lentivirus. To generate short hairpin RNAs (shRNA) in a lentivirus 
delivery system, 293 T cells (60% confluent) were transfected with a mix of the shRNA-encoding DNAs (5 μg) 
pLKO.1-shMAPK12 for p38γ (Sigma, Clone ID TRCN0000006145) or pLKO.1-shMAPK14 for p38α (Sigma, 
Clone ID TRCN0000000509), VSV-G (0.5 μg) and ∆89 packaging DNA (4.5 μg) using the calcium chloride 
method. After overnight, the media was replaced, and 48 h later, the media containing the virus was collected and 
passed through PVDF filters. For cell infection, the virus-containing media was diluted 1:10 in buffer containing 
6 mg/l of of polybren, incubated for 10 min and then placed on the cell monolayer. The following day media was 
replaced, and 24 h later the cells started to be selected with puromycin (1 μg/ml) for 24–48 h. Selected cell popu-
lations were cultured in media with puromycin (1 μg/ml).
www.nature.com/scientificreports/
1 2SCIENtIfIC REPORTS | 7: 11367  | DOI:10.1038/s41598-017-11309-7
Transfection with siRNAs. Cells were grown up to 60% confluence in 60 mm dishes and were transfected 
using Dharmafect transfection kit according to the manufacturer’s instruction with 5 μl of 25 μM siRNAs for 
c-Myc (ID 103828, Life Technologies, AM16708) and PPARGC1A (ID 108385, Life Technologies, AM51331) or 
scrambled (Ambion 4390843) as a control, to the final concentration of 65 nM. Cells were plated 48 h later and led 
to recover for 16 h before proceeding with the experiment.
Annexin V/PI staining. Cell death was assayed using FITC Annexin V kit (BD Pharmingen, 556547). The 
day before the experiment, 2 × 105 cells/well were plated on a 6-well dish. After appropriate treatments, media 
was collected into 2 ml Eppendorf tube. The cell monolayer was washed once with PBD and 200 μl of trypsin was 
added. Cells were collected using the previously removed media. The whole population of dead and live cells was 
centrifuged for 5 min at 1000 rpm. Cells were wash once with 1x Binding buffer and re-suspended in 500 μl of 
Binding buffer in concentration 1 × 106 cells/ml. 100 μl of the solution (1 × 105 cells) was transferred into a new 
Eppendorf tube and 4.5 μl of FITC Annexin V were added. Staining was left for 20 min at RT in the dark, after 
which 450 μl of Binding buffer and 5 μl of PI solution was added. Samples were transferred to ice and analysed 
immediately.
Proliferation assays. Cells were seeded at the density 3.5 × 104 cells/well into 96 well plates 16 h prior to 
the treatments. Cell proliferation was analysed using the MTT Cell Growth Assay (Merck Millipore, CT02). The 
increased cell proliferation is presented as a fold change in absorbance of the treated cells with respect to the 
untreated controls measured at day 0.
ATP measurement. ATP detection was assayed using an ATP measurement kit (Invitrogen, A22066). After 
treatments, cells were washed once with TBS, trypsinized and pelleted by centrifugation. Samples were imme-
diately frozen on dry ice and stored at −80 °C. For ATP detection, frozen pellets containing 5–7 × 105 cells were 
used. For sample preparation, 100 μl of boiling MQ water was added and the tubes were placed at 95 °C for 3 min 
and then on ice. To remove cellular fragments, samples were centrifuged for 5 min at 13000 rpm. Supernatants 
were collected and transferred to a new tube. Cellular lysates were diluted 3–5 times and levels of ATP were 
analysed according to the protocol provided by the manufacturer. Values were normalized to the cell numbers.
Cellular respiration. Cells were plated 12 h prior to the experiment at 4 × 104 cells into each well of a XF 
cell microplate in a total volume of 150 μl of DMEM containing 10 mM glucose and 2 mM glutamine. After 4 h, 
an additional 250 μl of media was added. Experiment was started by washing cells once with XF Cell Mito Stress 
Test Assay Medium and adding 500 μl/well of Assay Medium for the control and 500 μl/well of Assay Medium 
containing 1 μg/ml of tetracycline for MKK6 expression. After 12 h of induction measurement of the OCR begun. 
One h prior to the assay, the plate was placed in a 37 °C incubator without CO2. Meanwhile a cartridge port 
plate hydrated in an incubator without CO2 was prepared according to the manufacture’s recommendations. For 
the study, we used 1 μM oligomycin, 0.5 μM carbonyl cyanide m-chlorophenyl hydrazine (CCCP), 0.5 μM rote-
none and antimycin. Oxygen consumption was measured using XFp Extracellular Flux Analyzer from Seahorse 
Bioscience and normalized towards protein quantity.
GSH content. Total glutathione (GSSG + GSH) and reduced (GSH) glutathione were measured using the 
GSH/GSSG-Glo™ Assay (Promega). 5000 cells were plated into 96 well plates 18 h before the experiment. After 
treatment, media was removed and 50 μl of Total/Oxidized Glutathione Lysis Reagent was added and incubated 
5 min on a plate shaker. Next 50 μl of Luciferin Generation Reagent was added into all wells and incubated at RT 
for 30 min. 100 μl of Luciferin Detection Reagent was added, incubated for 15 min and luminescence was meas-
ured. Data normalization was performed towards cell number.
Mitochondria membrane potential. Each well of a 6 well dish received 2 ml of fresh complete medium 
containing 200 nM TMRE, and cells were incubated for 30 min in the dark at 37 °C. To remove the unbound 
probe, cells were washed once with PBS, trypsinized and resuspended in 500 μl of PBS containing aprotinin (1 μg/
ml). Mitochondria membrane potential was assayed immediately by flow cytometry.
Mitochondrial mass. Mitochondrial content was assayed by staining with Mitotracker Deep Red 
(Invitrogen). Each well of a 6 well dish, containing approximately 2 × 105 cells received 2 ml of complete media 
with 200 nM Mitotracker Deep Red. After incubation for 30 min at 37 °C, the incubation media was removed and 
cells were washed once with PBS, trypsinized and resuspended in 500 μl of PBS containing aprotinin (1 μg/ml). 
Mitochondrial content was immediately assayed by flow cytometry.
Mitochondrial and genomic DNA extraction and quantification. Cells were plated in triplicates in 
32 mm plates and treated for the desired periods of time. After the treatment cells were trypsinized, washed in 
PBS and counted. 1 × 106 cells were lysed in 515 μl of Lysis Solution (75 mM NaCl, 50 mM EDTA, 0.02% SDS, 
0.4 mg/ml proteinase K) and incubated at 50 °C for 2 h. After adding one volume of isopropanol, samples were 
incubated at 4 °C for 2 h. Samples were centrifuged for 30 min at 8500 rpm at 4 °C. The pellet was washed with 70% 
cold ethanol, air dried, resuspended in 50 μM TE and stored at −20 °C. To perform RT-PCR, 2 μl of DNA (100 
ng/μl), 5 μl of Syber Green, 5 μl of MQ water and 0.5 μl of Forward and Reverse primers were mixed. The ratio 
between genomic and mitochondrial DNA was calculated using primers towards Actin B and COXII, respectively.
ROS detection. Two different probes were used to detect ROS production, 2′,7′-dichlorofluorescin diacetate 
(DCFH-DA) (Sigma, D6883), which detects general oxidation, and MitoSOX™ Red (ThermoFisher scientific, 
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M36008), specific for mitochondrial ROS. One day prior to the treatments, 2 × 105 cells were plated per well in 
a 6 well dish. To visualize ROS, DCFH-DA (final concentration 10 μM) or MitoSox (final concentration 5 μM) 
were added to the media for the last 30 min. After the incubation media was removed, cells were washed once 
with PBS, trypsinized and resuspended in 500 μl of PBS containing 1.4 μg/ml aprotinin. Analysis was performed 
immediately by flow cytometry.
Lipid droplets. Cells were plated on 6 well plates and treated for the desired periods of time. A 0.5 µM solu-
tion of Nile Red in PBS was prepared and added to the cell monolayer for 10 min at RT. Cells were collected by 
trypsinization, re-suspended in 500 μl of PBS and analysed on a flow cytometer Ex/Em = 552/636 nm.
Glucose consumption and glutamine consumption and lactate production. Cells (5 × 105 per 
60-mm plate) were plated in duplicates 18 h prior the experiment in media containing 10 mM glucose and 2 mM 
glutamine. The following day, cells for time 0 were collected and counted. Meantime fresh media containing 
10 mM glucose and 2 mM glutamine were added was added to the other plates. At each time point, cells were 
trypsinized and counted, and media was collected and stored at −20 °C. D-glucose was determined by a modifi-
cation of the hexokinase/glucose 6-phosphate dehydrogenase spectrophotometric assay45 by using commercial 
reagents. Glutamine was determined by conversion first to glutamate through glutaminase reaction and subse-
quently quantification of the glutamate concentration. Glutamate concentration was determined by its conversion 
to α-ketoglutarate through glutamate dehydrogenase in the presence of ADP and NAD+45. L-lactate in the media 
was determined by spectrophotometry45 based on the oxidation of lactate to pyruvate by lactate dehydrogenase 
and NAD+ in the presence of hydrazine. Production of NAD(P)H was measured at 340 nm in a Cobas-Mira Plus 
analyzer. The consumption of glucose and glutamine and the production of lactate in the media were corrected 
by time and the number of cells present during all the incubation period. Linear growth between each incubation 
time was assumed. All results were expressed as μmol × million cells−1 × h−1.
Intracellular ammonia accumulation. Ammonia was detected using Ammonia Assay Kit (Abcam, 
ab83360). Cells (5 × 105 per 60-mm plate) were plated in duplicates 18 h prior the experiment. After the treat-
ment, cells were homogenized in the Assay Buffer to have final concentration 2 × 106 cells/100 μl and centrifuged 
at 13000 × g for 10 min at 4 °C. 10 μl of supernatant was used for the analysis according to the manufacturer’s 
recommendations.
mRNA expression analysis. Total RNA was extracted from cells using the RNA mini kit from Ambion 
according to the manufacturer’s instructions. To determine RNA concentrations, the absorbance at 260 nm 
was measured. cDNA was obtained from 1 μg of the purified RNA using SuperScript II Reverse Transcriptase 
(Invitrogen) in a final volume of 20 μl. For RT-PCR, 4 μl of cDNA (15 ng/reaction) were loaded in triplicates in a 
96-well plate and 6 μl of the mix reaction were added. The plate was sealed and centrifuged for 1 min at 200  × g 
and run as follows: 50 °C for 2 min, 95 °C for 10 min, 40 cycles of denaturation at 95 °C for 15 s, annealing at 
56 °C for 15 s, elongation at 72 °C for 60 s, and three final steps of 95 °C for 15 s, 60 °C for 2 min and 95 °C for 15 s. 
GAPDH was used as a reference and the ΔΔC(t) method was used to quantify gene expression. The primer 
sequences are presented in Table 1.
Immunoblotting. Approximately 40 μg of proteins were separated on 10 or 12% SDS-PAGE Laemmli gels, 
depending on the molecular weight of the protein of interest. A wet-blotting system (Bio Rad) was used for pro-
tein transfer to nitrocellulose membrane, which were stained with 0.1% Ponceau (in 5% acetic acid) to evaluate 
transfer efficiency. Membranes were blocked for 1 h at RT in 5% non-fatty milk (in PBS). Primary antibodies 
were diluted in PBS with 5% BSA and 0.1% Tween 20. The following antibodies were used at a concentration of 
















Table 1. Primers used for RT-PCR analysis.
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(Cell Signaling, 3044 S), P-Hsp27 (Ser82) (StressGene, SPA-523), P-PDHE1-A type I (Ser293) (Merk Millipore, 
ABS204), c-Myc (Abcam, ab32072), Tim-44 (BD, T14720), TFAM (Abcam, ab131607), VDAC-1 (Abcam, 
ab14734), P-CREB (Ser133) (Cell Signaling, #9191), P-eIF4E (Ser209) (Cell Signaling, #9741). The MKK6 rabbit 
antiserum has been previously described46, and the p38γ antibody was kindly provided by Ana Cuenda (CNB, 
Madrid). Tubulin (Sigma, T9026) was used at 1:5000 as a loading control. Secondary Alexa Fluor-conjugated anti-
bodies were diluted 1:5000 in 1% non-fatty milk. Membranes were analysed using the Odyssey Infrared Imaging 
System (Li-Cor Biosciences).
Incorporation of 14C into lipids and proteins. Cells were seeded at a density of 2.5 × 105 cells/well 
(6-well plate), and 18 h later the medium was changed and cells were subjected to different treatments to acti-
vate or inhibit the p38 MAPK pathway. After 6 h, the medium was supplemented with trace amounts of [U14C] 
glucose or [U14C] glutamine (0.1 μCi/ml) and the cells were further incubated for 24 h. Experiments were con-
ducted in triplicate. Cells were washed with PBS, collected using 200 μl 0.5% Triton X-100, and stored at −80 °C 
for 1–5 days. After thawing, 180 μl of the suspension was taken for the lipid and protein extraction. First 600 μl 
of chloroform/methanol (2:1) was added and vortexed for 1 min. Later the mixture was centrifuged 500  × g for 
5 min. Lipid-rich chloroform phase was air dried overnight and resuspended in 200 μl of chloroform. Protein rich 
phase were washed with methanol and spun at 14,200  × g for 5 min and air dried overnight. Next day, the protein 
fraction was resuspended in 200 μl of guanidine hydrochloride 6 M and was incubated at 65 °C for 15 min. 14C 
incorporation was measured over 1 min per sample using a MicroBeta2 scintillation counter (PerkinElmer) and 
was normalized for protein concentration.
Statistical analysis. All the statistics were performed using GraphPad Prism software using Student t-test 
unpaired two-tailed analysis: (****)p < 0.00001, (***)p < 0.0001, (**)p < 0.001, (*)p < 0.01.
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